DOI : 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 05 · Volume 58 · 1987 DOI: 10.1055/s-008-39920


XIth International Congress on Thrombosis and Haemostasis
Brussels, Belgium, 06.–10.07.1987

Abstracts (HTML) List of Authors
1361
Cornelli, U; Welena, J M; Fareed, J; Huan, X; Hoppensteadt, D: ANTITHROMBOTIC ACTIONS OF A SULFOMUCOPOLYSACCHARIDE MIXTURE (ATERIOD) IN ANIMAL MODELS
1362
Walenga, J M; Fareed, J; Petitou, M; Lormeau, J C; Samama, M; Choay, J: ANTITHROMBOTIC ACTIVITY OF A SYNTHETIC HEPARIN PENTASACCHARIDE IN A RABBIT STASIS THROMBOSIS MODEL USING DIFFERENT THROMBOGENIC CHALLENGES
1363
Zimmerman, R A; Rieger, C T; Hübner, K; Harenber, C W; Kübler, W: EXPERIMENTAL THROMBUS FORMATION AND HAEMOSTASIS OF DIFFERENT LOW MOLECULAR WEIGHT HEPARINS AND DOSAGES
1364
Fareed, J; Walenga, J M; Hoppensteadt, D; Emanuele, R N; Racanell, A: PHARMACOLOGIC INEQUIVALENCE OF LOW MOLECULAR WEIGHT HEPARINS
1365
Bianchini, P; Nonn, R; Fareed, J; Walenga, J M; Kumar, A: STUDIES ON THE ANTITHROMBOTIC ACTION OF A LOW MOLECULARWEIGHT HEPARIN OBTAINED FROM BEEF MUCOSAL ORIGIN AND PEROXIDATIVE CLEAVAGE
1366
Scully, M F; Decousus, H A; Ellis, V; Girard, P; Parker, C; Kakkar, V V: MEASUREMENT OF HEPARIN IN PLASMA: INFLUENCE OF INTER-SUBJECT AND CIRCADIAN VARIABILITY IN HEPARIN SENSITIVITY ACCORDING TO METHOD
1367
ten Cate, H; HENNY, Ch P; Sturk, A; Prins, A; ten Cate, J W: COMPARATIVE INVESTIGATION OF CLOTTING AND CHROMOGENIC ASSAYS FOR HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN-(OID) IN PLASMA OF VOLUNTEERS AND PATIENTS
1368
Porte, R J; de Jong, E; Knot, EA R; de Maat, MP M; Terpstra, O T; van Urk, H; Groenald, TH N: AMBULANT MONITORING OF HEPARIN AND HAEMOSTASIS DURING VASCULAR SURGERY
1369
Seveso, M P; Macagni, A; Viganò D’Angelo, S; Dettori, A G; Bonini, P A; D’Angelo, A: ACTIVATED PARTIAL THROMBOPLASTIN TIME MONITORING OF HEPARIN THERAPY: COMPARISON OF INSTRUMENTS AND REAGENTS
1370
Sternberger, A; Haas, S; Breddin, K; Blümel, G: COMPARISON OF VARIOUS AMI DOLYTIC HEPARIN ASSAYS: REPORT OF A COLLABORATIVE STUDY
1371
Brien, W; Inwood, M; Dillon, K: QUALITY ASSURANCE OF THERAPEUTIC HEPARIN/ORAL ANTICOAGULANT THERAPY IN A GENERAL TEACHING HOSPITAL
1372
Villians, Ph; Bouvier, J L; Le Corff, G; Elias, A; Juhan-vague, I; Serradimigni, G: DO APTT AND ANTI Ila ACTIVITY PERMIT THE PREDICTION OF THE EFFICIENCY OF HEPARIN THERAPY IN PATIENTS WITH PROXIMAL DEEP VEIN THROMBOSIS?
1373
Hobblen, P M J; Vogel, G MT; Meuleman, D G: PHARMACOKINETIC BEHAVIOUR OF ANTITHROMBOTIC AND BLEEDING ENHANCING EFFECTS OF VARIOUS HEPARIN(OID)S IN RATS: THEIR RELATION WITH INTERACTIONS WITH FACTORS IIa AND Xa
1374
Spyropulos, B; Fareed, J; Emanuel, R M; Hoppensteadt, D: COMPARATIVE PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED HEPARIN (HEP) AND A LOW MOLECULAR WEIGHT HEPARIN (LMWH) AS STUDIED BY AN EX VIVO FIBRINOPEPTIDE A (FPA) GENERATION TEST
1375
Norm, R; Fareed, J; Silber, I; Belo, A; Fenchel, R; McGuire, R: SUBCUTANEOUS PHARMACOKINETICS/PHARMACODYNAMICS OF A LOW MOLECULAR WEIGHT DERIVATIVE (RD 11885) AND UNFRACTIONATED HEPARIN (PM 16885) IN PRIMATES
1376
Decousus, H A; Scully, M F; Reynaud, J; Arnaud-Crozat, E; Boissier, C; Barral, R; Queneau, P; Reynaud, J; Parker, C; Kakkar, v v: CIRCADIAN CHANGES IN THE ANTICOAGULANT EFFECT OF HEPARIN. PHARMACODYNAMIC AND PHARMACOKINETIC EFFECT
1377
Bode, V; Franz, R; Welzel, D; Wolf, H; Harenberg, C: KINETICS OF LOW MOLECULAR WEIGHT HEPARIN IN MAN DETERMINED BY PROTAMINE CHLORIDE
1378
Pangrazzl, J; Oreste, P; Torri, G; Maggi, A; Donati, M B; Casu, B: BLEEDING EFFECTS ASSOCIATED WITH HEPARIN contaminants
1379
Emanuele, R M; Lormeau, J C; Choay, J; Fareed, J: THE MOLECULAR WEIGHT DEPENDENT EFFECTS OF HEPARIN ON THROMBOPLASTIN ACTIVATED PROTEASES
1380
Emanuele, R M; Fareed, J: THE EFFECT OF MOLECULAR WEIGHT ON THE RELATIVE BIOAVAILABILITY OF HEPARIN
1381
Porta, R; Pescador, R; Niada, R; Mantovani, M; Prino, G: FIBRINOLYTIC POTENCY OF NON ANTICOAGULANT, OXI-EEDUCED SLOW AND FAST MOVING HEPARINS
1382
Walenga, J M; Fareed, J; Petitou, M; Lormeau, J C; Samama, M; Choay, J: THE ROLE OF A 3-0 SULFO GROUP IN THE GLUCOSAMINE RESIDUE OF A SYNTHETIC OLIGOSACCHARIDE FOR THE DETERMINATION OF ANTITHROMBOTIC ACTIONS
1383
Bara, L; Walen-ga, J M; Petitou, M; Samama, M; Fareed, J; Choay, J: STUDIES ON THE MECHANISM OF THE ANTITHROMBOTIC ACTION OF A CHEMICALLY SYNTHESIZED HEPARIN PENTASACCHARIDE
1383
Mazurov, A V; Si-nitsin, V E; Repin, V S: HEPARIN POTENTIATES PLATELET ADHESION AND AGGREGATION ON COLLAGEN SUBSTRATES. ABSENCE OF INHIBITION BY ASPIRIN
1385
Taylor, C; Baugh, R F: IN VITRO DEMONSTRATION OF "HEPARIN REBOUND"
1386
Takamatsu, J; Saito, H; Kamiya, T; Muranaka, Y; Minami, Y F; Fan, H T: A NEW MUCOPOLYSACCHARIDE FROM STICHPUS JAPONICUS(SEA CUCUMBER) AND ITS ANTICOAGULANT PRORETIES
1387
Messmore, H; Griffin, B; Seghatchian, J; Coyne, E: HIGH CONCENTRATIONS OF HEPARIN ARE MORE INHIBITORY TO PLATE- AGGREGATION IN-VITRO THAN ARE LOW MOLECULAR WEIGHT HEPARINS AND HEPARINOIDS AT THE SAME CONCENTRATION
1388
Vannucchi, S; Pasquali, F; Bianchi-ni, P; Ruggiero, M: BINDING AND METABOLISM OF HEPARIN BY ENDOTHELIAL CELLS
1389
Rathjen, A; Geczy, Carolyn L: PRODUCTION AND CHARACTERISATION OF MONOCLONAL ANTIBODIES AGAINST HEPARIN Deborah
1390
Parker, C J; Huber, D E; Hedges, A R; Kakkar, V V: A TRIAL OF SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF LOW MOLECULAR WEIGHT (LMW) HEPARIN AND UNFRACTIONATED (UF) HEPARIN IN THE TREATMENT OF ESTABLISHED DEEP VENOUS THROMBOSIS (DVT)
1391
Harenberg, J; Leber, P; Raedsch, R; Zimmermann, R: LONG TERM PROPHYLAXIS OF THROMBOEMBOLISM IN OUTPATIENTS WITH LOW MOLECULAR WEIGHT HEPARIN
1392
Harenberg, I; Kallenbach, B; Martin, U; Zimmermann, R: RANDOMIZED DOUBLE BLINDED STUDY OF NORMAL AND A LOW MOLECULAR WEIGHT HEPARIN IN GENERAL MEDICAL PATIENTS
1393
Bergqvist, D; Frisel, J; Hallböök, T; Horn, A; Lindhagen, A; Ljungndér, H; Ljungström, K G; Mätzsch, T; Onarheim, H; Risberg, B; Törngren, S; Örtenwall, P; Burmark, U S: PROPHYLAXIS AGAINST POSTOPERATIVE DEEP VEIN THROMBOSIS (DVT)- A DOUBLE-BLIND MULTICENTER TRIAL COMPARING A HEPARIN FRAGMENT GIVEN ON THE EVENING BEFORE SURGERY WITH CONVENTIONAL LOW DOSE HEPARIN
1394
Kußmann, J; Spannaql, M; Boehnke, J; Kückel-haus, H G; Schramm, W: LOW DOSE HEPARIN PROPHYLAXIS IN HIP FRACTURE SURGEY -HEPARIN EFFECT; INHIBITORS; FIBRINOLYSIS AND INCIDENCE OF DVT
1395
Hedner, U; Mätzsch, T; Berggvist, D; Fredin, H; Østergaard, P: SAFE DOSING OF LMW HEPARIN IN HIP SURGERY
1396
Sadakata, H; Iri, H; Uchiyama, T; Andoh, K; Tanaka, H; Kobayashi, N; Maekawa, T: PROSPECTIVE STUDY ON DOSE SCHEDULE OF HEPARIN THERAPY FOR DIC COMPLICATION IN LEUKEMIA PATIENTS